NLM Logo

veltuzumab MeSH Supplementary Concept Data 2022


MeSH Supplementary
veltuzumab
Unique ID
C493846
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C493846
Entry Term(s)
HA20
IMMU 106
IMMU-106
monoclonal antibody IMMU-106
Pharm Action
Antineoplastic Agents
Registry Number
BPD4DGQ314
Previous Indexing
*ANTIBODIES, MONOCLONAL (2004-2011)
Heading Mapped to
*Antibodies, Monoclonal, Humanized
Frequency
32
Note
humanized anti-CD20 monoclonal antibody; used in combination with the humanized anti-CD22 antibody, epratuzumab, for the therapy of non-Hodgkin's lymphoma
Source
Clin Cancer Res 2004 Apr 15;10(8);2868-78
Date of Entry
2004/12/09
Revision Date
2019/11/01
veltuzumab Preferred
HA20 Narrower
IMMU-106 Narrower
page delivered in 0.008s